Search Results 321-330 of 3814 for Schweizer Suchmaschine 🔍 www.41.gs
About this study. Subjects will receive an oral dose of SER-109 in 4 capsules once daily for 3 consecutive days in Treatment Group I or matching placebo ...
Drugs used in chemotherapy, such as cisplatin, vincristine sulfate, cyclophosphamide and lomustine, work in different ways to stop the growth of tumor cells, ...
The purpose of this study is to bring our expertise with community-engaged research to the clinical setting through the Health Equity Section (HES) in order to ...
About this study. RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen citrate, goserelin acetate, ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Search. Request an Appointment · Find a Doctor ... Search. Search. All Mayo Clinic Topics. Care at Mayo ... Sponsor Protocol Number: GS-US-354-0101. About ...
StowellOrbison/Surgical Pathology/Autopsy AwardUnited States and Canadian Academy of Pathology. 2015. Best Oral Case PresentationCalifornia Society of ...
The purpose of this study is to investigate the utility of using a PUMA (Proteins, mUtations, Methylated DNA, and Aneuploidy markers) platform to prognosticate ...
The purpose of this study is to define the prevalence and phenotype of nail fold video capillaroscopy abnormalities in patients with Gastric Antral Vascular ...
The purpose of this study is to assess the burden that patients and their caregivers face to due primary hyperoxaluria (PH). Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each year.